Preferences Decline Accept What happens here matters everywhere. by Lisa Stiffler on Nov 6, 2025 at 10:49 amNovember 6, 2025 at 10:58 am Parse Biosciences co-founders are CTO Charles Roco and CEO Alex Rosenberg. (Parse Photo) Seattle's Parse Biosciences is teed up for an acquisition by Qiagen, a Netherlands-based holding company, in a $225 million cash deal announced today. The transaction is expected to close in December. Parse was co-founded in 2018 by Alex Rosenberg, who was a University of Washington po ...